NCCN-Directed Guidelines Driving PV Treatment in Clinical Practice
Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.
Source: ajmc.com
Stay updated with breaking news from Pv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines.
In a study that did not achieve its recruitment goal, the patients who benefited most from the vaccine had previously responded to immunotherapy.
Key opinion leaders discuss data on the use of ruxolitinib in patients with polycythemia vera.
The US automaker has one of the most challenging jobs inside Stellan...
Risk factors for developing polycythemia vera (PV) are discussed by Aaron Gerds, MD, MS.